跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 165,076 条关于
“RAS(ON)”
全部
165,076
临床试验
127,760
药物
709
机构
1,020
资讯
35,587
8天前
FDA Approves Daraxonrasib (Rasonque), First-in-Class RAS(ON) Inhibitor for Metastatic Pancreatic Cancer
上个月
BeOne Medicines and Revolution Medicines Forge Multi-Part Collaboration to Advance RAS(ON) Inhibitors for RAS-Addicted Cancers
2个月前
Adlai Nortye Advances First-in-Class Pan-RAS(ON) ADC AN4035 into Phase I Trial for RAS-Addicted Solid Tumors
2年前
Revolution Medicines' RAS(ON) Inhibitors Show Promise in Lung and Pancreatic Cancers
2年前
Revolution Medicines' RMC-6236: A Novel Pan-RAS(ON) Inhibitor Shows Promise in 'Undruggable' Tumors
11个月前
Revolution Medicines Appoints Alan Sandler as Chief Development Officer to Advance RAS-Targeted Cancer Pipeline
去年
Revolution Medicines Secures $2 Billion Funding Deal with Royalty Pharma for RAS Cancer Drug Development
去年
Revolution Medicines and Summit Therapeutics Launch Clinical Collaboration to Test RAS Inhibitor Combinations with Bispecific Antibody
9个月前
Revolution Medicines Receives FDA Breakthrough Therapy Designation for Daraxonrasib in KRAS G12-Mutant Pancreatic Cancer
去年
FDA Grants Breakthrough Therapy Designation for Daraxonrasib in KRAS-Mutated Pancreatic Cancer
第 1 页,共 3559 页
上一页
下一页